68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients.

Chen LiuTeli LiuNing ZhangYiqiang LiuNan LiPeng DuYong YangMing LiuKan GongXing YangHua ZhuKun YanZhi Yang

Published in: European journal of nuclear medicine and molecular imaging (2018)

Semi-quantitative analysis indexes of 68Ga-PSMA-617 PET/CT imaging can be used as "imaging biomarkers" to predict risk stratification and metastatic risk of prostate cancer.

Keyphrases

pet ct
prostate cancer
radical prostatectomy
high resolution
squamous cell carcinoma
small cell lung cancer
positron emission tomography
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
patient reported outcomes
fluorescence imaging
patient reported
pet imaging